Qingdao Haier Biomedical Co Ltd Cash Flow Quality Index
Qingdao Haier Biomedical Co Ltd cash flow quality index. Qingdao Haier Biomedical Co Ltd (688139) has a Cash Flow Quality Index of 0.05x as of June 2023. Operating cash flow of CN¥7.33 Million is below net income of CN¥140.93 Million, suggesting accrual-heavy earnings not yet converted to cash. See 688139 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Qingdao Haier Biomedical Co Ltd (2016–2025)
Cash flow quality index of Qingdao Haier Biomedical Co Ltd from 2016 to 2025. Historical Cash Flow Quality Index for Qingdao Haier Biomedical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Qingdao Haier Biomedical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Qingdao Haier Biomedical Co Ltd Cash Flow Quality Index by Year (2016–2025)
Qingdao Haier Biomedical Co Ltd cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Qingdao Haier Biomedical Co Ltd. For the full cash flow conversion analysis, see 688139 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.07x | CN¥267.89 Million | CN¥250.73 Million | ▲ +34.3% |
| 2024 | 0.80x | CN¥291.67 Million | CN¥366.63 Million | ▲ +29.6% |
| 2023 | 0.61x | CN¥249.26 Million | CN¥406.07 Million | ▼ -41.7% |
| 2022 | 1.05x | CN¥632.43 Million | CN¥600.79 Million | ▲ +36.2% |
| 2021 | 0.77x | CN¥632.43 Million | CN¥818.33 Million | ▼ -57.7% |
| 2020 | 1.83x | CN¥696.62 Million | CN¥380.95 Million | ▲ +18.7% |
| 2019 | 1.54x | CN¥280.49 Million | CN¥182.06 Million | ▲ +17.8% |
| 2018 | 1.31x | CN¥149.00 Million | CN¥113.96 Million | ▼ -46.8% |
| 2017 | 2.46x | CN¥148.32 Million | CN¥60.39 Million | ▲ +37.1% |
| 2016 | 1.79x | CN¥220.72 Million | CN¥123.21 Million | — |